Skip to main content

. 1977 Sep;61(1):116P–117P.

Evidence for two distinct types of postsynaptic alpha-adrenoceptor [proceedings]

S M Bentley, G M Drew, S B Whiting

PMCID: PMC1667641 PMID: 199306

116P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cambridge D., Davey M. J., Massingham R. Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings]. Br J Pharmacol. 1977 Mar;59(3):514P–515P. [PMC free article] [PubMed] [Google Scholar]
Cavero I. Cardiovascular effects of prazosin in dogs. Clin Sci Mol Med Suppl. 1976 Dec;3:609s–612s. doi: 10.1042/cs051609s. [DOI] [PubMed] [Google Scholar]
Cohen B. M. Prazosin hydrochloride (CP-12,299-1), an oral anti-hypertensive agent: preliminary clinical observations in ambulatory patients. J Clin Pharmacol J New Drugs. 1970 Nov-Dec;10(6):408–417. [PubMed] [Google Scholar]
Moulds R. J., Jauernig R. A. Mechanism of prazosin collapse. Lancet. 1977 Jan 22;1(8004):200–201. doi: 10.1016/s0140-6736(77)91808-6. [DOI] [PubMed] [Google Scholar]
Wood A. J., Phelan E. L., Simpson F. O. Cardiovascular effects of prazosin in normotensive and genetically hypertensive rats. Clin Exp Pharmacol Physiol. 1975 Jul-Aug;2(4):297–304. doi: 10.1111/j.1440-1681.1975.tb01836.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (298.0 KB)

RESOURCES